METHYLPREDNISOLONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methylprednisolone, and what generic alternatives are available?
Methylprednisolone is a drug marketed by Elkins Sinn, Organon Usa Inc, Amneal, Chartwell Rx, Duramed Pharms Barr, Heather, Invatech, Jubilant Cadista, Novast Labs, Par Pharm, Praxgen, Sandoz, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms, Epic Pharma Llc, Eugia Pharma, Hong Kong, Par Sterile Products, Sagent Pharms Inc, Slayback Pharma Llc, Teva Pharms Usa, Abraxis Pharm, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Teva Parenteral, and Tianjin Kingyork. and is included in sixty-nine NDAs.
The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylprednisolone
A generic version of METHYLPREDNISOLONE was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
Summary for METHYLPREDNISOLONE
US Patents: | 0 |
Applicants: | 30 |
NDAs: | 69 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 820 |
Patent Applications: | 4,977 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for METHYLPREDNISOLONE |
Drug Sales Revenues: | Drug sales revenues for METHYLPREDNISOLONE |
What excipients (inactive ingredients) are in METHYLPREDNISOLONE? | METHYLPREDNISOLONE excipients list |
DailyMed Link: | METHYLPREDNISOLONE at DailyMed |
Recent Clinical Trials for METHYLPREDNISOLONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ossium Health, Inc. | Phase 1/Phase 2 |
ITB-Med LLC | Phase 1/Phase 2 |
Massachusetts General Hospital | Phase 1/Phase 2 |
Pharmacology for METHYLPREDNISOLONE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for METHYLPREDNISOLONE
Anatomical Therapeutic Chemical (ATC) Classes for METHYLPREDNISOLONE
US Patents and Regulatory Information for METHYLPREDNISOLONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 089144-001 | Mar 28, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-005 | Jul 18, 2011 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Epic Pharma Llc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 086903-001 | Oct 20, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |